Skip to main content

Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product

    This report describes the utilization of ibrexafungerp during pregnancy among patients with live-birth deliveries and describes demographic and pregnancy characteristics among all pregnant patients as well as among pregnant patients with ibrexafungerp use during pregnancy.

    The study period includes data from June 1, 2021 to November 30, 2022. We distributed this request to six Rapid Sentinel Data Partners on January 4, 2023.

    Additional Details
    FDA Center
    Time Period
    June 1, 2021 - November 30, 2022
    Population / Cohort
    Females 15 years of age and older
    Data Sources
    Rapid Sentinel Distributed Database (SDD)